Chen Bi-Xi, Xie Boqia, Zhou Yang, Shi Liang, Wang Yanjiang, Zeng Lijun, Liu Xingpeng, Yang Min-Fu
Department of Nuclear Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Cardiac Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Front Cardiovasc Med. 2021 Oct 12;8:735082. doi: 10.3389/fcvm.2021.735082. eCollection 2021.
Peripheral biomarkers may be affected by various factors, their reliability in reflecting local cardiac inflammatory status in patients with atrial fibrillation (AF) needs further exploration. This prospective study was aimed to investigate the relationship between circulating biomarkers and local cardiac inflammation measured by epicardial adipose tissue (EAT) activity F-fluorodeoxyglucose (FDG) imaging in AF patients. From 2017 to 2018, 83 AF patients [43 persistent AF (PsAF) and 40 paroxysmal AF (PAF)] referred for radiofrequency catheter ablation (RFCA) were recruited. Pre- and post-RFCA blood samples were collected to measure IL-6, IL-8, IL-10, IL-18, TNF-α, Hsp27, Hsp60, Hsp70, PDGF-BB, MMP-2, MMP-9, MPO, TGF-β1, Gal-3, and sST2. Pre-RFCA FDG images were obtained to assess EAT activity. Sixty-seven patients (35 PAF and 32 PsAF) received RFCA were regularly followed for 27 (24, 29) months. Higher hsCRP and IL-6 and lower TGF-β1 were demonstrated in PsAF patients compared with PAF patients. Multivariate logistic regression analysis demonstrated that Gal-3 (OR: 1.221, 95% CI: 1.024-1.456, = 0.026) and MPO (OR: 1.002, 95% CI: 1.001-1.003, = 0.027) were independently correlated with EAT activity. The percentage decrease of Hsp60 linearly correlated with that of EAT activity post-RFCA (Spearman = 0.455, = 0.019). Seventeen patients (10 PsAF and 7 PAF) had AF recurrence, but none of the selected biomarkers were predictive of post-RFCA recurrence. Our findings demonstrated that in patients with AF, Gal-3 correlated with local cardiac inflammation, and Hsp60 was associated with the alleviation of cardiac inflammation after RFCA.
外周生物标志物可能受多种因素影响,其在反映心房颤动(AF)患者局部心脏炎症状态方面的可靠性有待进一步探究。本前瞻性研究旨在探讨循环生物标志物与通过心外膜脂肪组织(EAT)活性氟脱氧葡萄糖(FDG)成像测量的局部心脏炎症之间的关系。2017年至2018年,招募了83例因射频导管消融(RFCA)就诊的AF患者[43例持续性AF(PsAF)和40例阵发性AF(PAF)]。在RFCA前后采集血样,检测白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)、白细胞介素-18(IL-18)、肿瘤坏死因子-α(TNF-α)、热休克蛋白27(Hsp27)、热休克蛋白60(Hsp60)、热休克蛋白70(Hsp70)、血小板衍生生长因子-BB(PDGF-BB)、基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)、髓过氧化物酶(MPO)、转化生长因子-β1(TGF-β1)、半乳糖凝集素-3(Gal-3)和可溶性ST2(sST2)。获取RFCA前的FDG图像以评估EAT活性。67例接受RFCA的患者(35例PAF和32例PsAF)被定期随访27(24,29)个月。与PAF患者相比,PsAF患者的高敏C反应蛋白(hsCRP)和IL-6水平更高,而TGF-β1水平更低。多因素逻辑回归分析表明,Gal-3(比值比:1.221,95%置信区间:1.024-1.456,P = 0.026)和MPO(比值比:1.002,95%置信区间:1.001-1.003,P = 0.027)与EAT活性独立相关。RFCA后Hsp60的降低百分比与EAT活性的降低百分比呈线性相关(Spearman相关系数 = 0.455,P = 0.019)。17例患者(10例PsAF和7例PAF)发生AF复发,但所选生物标志物均不能预测RFCA后的复发情况。我们的研究结果表明,在AF患者中,Gal-3与局部心脏炎症相关,而Hsp60与RFCA后心脏炎症的减轻有关。